TROTT, KLAUS RUDIGER
 Distribuzione geografica
Continente #
NA - Nord America 1.092
AS - Asia 809
EU - Europa 755
SA - Sud America 48
AF - Africa 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.712
Nazione #
US - Stati Uniti d'America 1.076
CN - Cina 546
IE - Irlanda 227
SG - Singapore 138
UA - Ucraina 102
FI - Finlandia 98
RU - Federazione Russa 95
DE - Germania 83
HK - Hong Kong 81
SE - Svezia 59
BR - Brasile 44
GB - Regno Unito 35
IT - Italia 22
BE - Belgio 15
CA - Canada 10
JP - Giappone 7
IQ - Iraq 5
VN - Vietnam 5
AR - Argentina 4
FR - Francia 4
LT - Lituania 4
MX - Messico 4
PL - Polonia 4
AZ - Azerbaigian 3
BD - Bangladesh 3
ES - Italia 3
IR - Iran 3
KR - Corea 3
MA - Marocco 3
AU - Australia 2
IN - India 2
KG - Kirghizistan 2
TR - Turchia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
LB - Libano 1
NI - Nicaragua 1
NL - Olanda 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 2.712
Città #
Dublin 225
Chandler 192
Jacksonville 151
Nanjing 120
Beijing 109
Dallas 106
Hong Kong 81
Ashburn 62
Singapore 59
Nanchang 55
Ann Arbor 54
Boardman 52
Hebei 40
Princeton 38
Shenyang 37
Lawrence 35
Wilmington 35
Changsha 34
Los Angeles 32
Medford 32
Munich 31
Jiaxing 29
Moscow 20
Hangzhou 19
Helsinki 18
Tianjin 18
Brussels 15
Shanghai 15
Redondo Beach 14
Turku 12
Buffalo 11
New York 10
Woodbridge 9
Milan 8
Des Moines 7
Norwalk 7
Tokyo 7
Boston 6
The Dalles 6
Toronto 6
Washington 6
Falls Church 5
Fairfield 4
Kunming 4
Verona 4
Warsaw 4
Brooklyn 3
Kerman 3
Stockholm 3
São Paulo 3
Zhengzhou 3
Baghdad 2
Baku 2
Belo Horizonte 2
Bishkek 2
Concord 2
Cork 2
Denver 2
Erbil 2
Falkenstein 2
Fulham 2
Fuzhou 2
Hanoi 2
Ho Chi Minh City 2
Houston 2
Jinan 2
Kidlington 2
Lanzhou 2
Mexico City 2
Montreal 2
Newark 2
Phoenix 2
Rabat 2
Rio de Janeiro 2
San Francisco 2
Seattle 2
São Vicente 2
Tashkent 2
Vilnius 2
Xi'an 2
Alegrete 1
Amsterdam 1
Ankara 1
Araraquara 1
Atlanta 1
Auburn Hills 1
Auckland 1
Belterra 1
Betim 1
Bom Despacho 1
Bratislava 1
Camapuã 1
Cambridge 1
Campina Grande 1
Campos do Jordão 1
Cantagallo 1
Carney 1
Castelo 1
Chengdu 1
Chennai 1
Totale 1.937
Nome #
ALLEGRO to ANDANTE: An application of radiotherapy data to low-dose radiation research 106
Biological mechanisms of normal tissue damage: Importance for the design of NTCP models 105
The ANDANTE project: a multidisciplinary approach to neutron RBE 97
Initial radiation damage events (the track structure approach) 97
Education and Training in the DoReMi project 96
Education and Training in DoReMi, MELODI and OPERRA 94
Gamma ray-induced bystander effect in tumour glioblastoma cells: a specific study on cell survival, cytokine release and cytokine receptors. 93
ALLEGRO: understanding the risks of normal tissue complications and second cancers following radiotherapy 93
Introduction to the MELODI Education and Training Forum Part 1 90
The risk of second cancers following proton therapy. 88
Second malignancies following breast cancer treatment: a case-control study based on the PERIDOSE methodology 88
Introduction to the MELODI Education and Training Forum Part 2: survival in a changing environment 88
Support and integration of education and training on low dose radiation research in Europe 87
Mechanisms of normal tissue response: a task of the EU project ALLEGRO on the risks to healthy tissues in RT 86
Radiobiological mechanisms of the response of normal tissue in RT as investigated within the EU project ALLEGRO on the risks to healthy tissues. 84
The ALLEGRO project: what more do we need to know about normal tissue complication probability? 80
Challenges of low dose exposure in medical uses of ionising radiation 80
ANDANTE: The project: a multidisciplinary approach to neutron RBE 80
The ANDANTE project: refining risk estimates from neutrons 77
Dosimetry for second cancer risk: the Euratom projects ALLEGRO and ANDANTE 75
ALLEGRO, Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy and ANDANTE, Multidisciplinary evaluation of the cancer risk from neutrons relative to photons using stem cells and the induction of second malignant neoplasms following paediatric radiation therapy 74
Normal tissue risk from radiotherapy The ALLEGRO Session at the ESTRO Anniversary conference 74
The DoReMi T+E initiatives: Current initiatives; options for networking; proposal to form a T+E network; achieving sustainability beyond DoReMi 73
Modelling the risk of health effects from the use of radiation therapy 72
Education and training to support radiation protection research in Europe: the DoReMi experience 72
The ANDANTE project: A multidisciplinary approach to neutron RBE 69
THE ALLEGRO PROJECT: AN OVERVIEW 67
The ANDANTE project: progress towards a re-evaluation of the risk from scattered neutrons during proton therapy 63
The ALLEGRO project: what is the relevance of second cancers after oncological treatment, and which information is required? 61
The ANDANTE Project: Progress after one year: meeting at ESTRO office. 60
The ANDANTE project: a multidisciplinary approach to neutron RBE 58
The risks to healthy tissues from the use of existing and emerging techniques for radiation therapy 56
The ALLEGRO project: a European consortium on Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy. 51
The EURATOM Project ALLEGRO: Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy 47
The risks to healthy tissues from the use of existing and emerging techniques for radiation therapy 46
Totale 2.727
Categoria #
all - tutte 11.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.583


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 3 26 3 39 10 38 27 10
2021/2022151 3 1 4 4 3 4 5 14 6 6 22 79
2022/2023555 57 42 3 44 53 58 0 31 246 8 7 6
2023/2024154 16 16 15 15 15 50 4 5 0 10 4 4
2024/2025481 6 39 14 19 32 5 43 13 126 5 65 114
2025/2026403 111 102 116 52 22 0 0 0 0 0 0 0
Totale 2.727